Is It Time to Ditch Isoproterenol for Bradycardia?
Is It Time to Ditch Isoproterenol for Bradycardia? A guest post by Scott Dietrich, PharmD (@PCC_PharmD) The acquisition cost of isoproterenol (Isuprel®) has dramatically increased from approximately $60 per vial in 2012 to over $2,150 per vial today, a nearly 4000% increase. In order to minimize costs associated with therapy, the following represents alternative agents that may be utilized in the management of bradyarrhythmia: Recommendations for the management of bradyarrhythmia based on the Advanced Cardiovasular [...]